+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Pruritus Therapeutic Market 2020-2024 - Product Image

Global Pruritus Therapeutic Market 2020-2024

  • ID: 5017675
  • Report
  • April 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Astellas Pharma Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • MORE
Global Pruritus Therapeutic Market 2020-2024

The pruritus therapeutic market and it is poised to grow by $ 3.63 bn during 2020-2024 progressing at a CAGR of 6% during the forecast period. The reports on pruritus therapeutic market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of pruritus and drug-induced pruritus. In addition, increasing prevalence of pruritus is anticipated to boost the growth of the market as well.

The pruritus therapeutic market analysis includes type segments and geographic landscapes.

The pruritus therapeutic market is segmented as below:

By Type
  • Renal pruritus
  • Cholestatic pruritus
  • Hematologic pruritus
  • Endocrine pruritus
  • Oncological pruritus
By Geography
  • North America
  • Europe
  • APAC
  • ROW
This study identifies the strong pipeline of expected launches as one of the prime reason driving the pruritus therapeutic market growth during the next few years.

The research presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The pruritus therapeutic market covers the following areas:
  • Pruritus therapeutic market sizing
  • Pruritus therapeutic market forecast
  • Pruritus therapeutic market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pruritus therapeutic market vendors that include Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd.. Also, the pruritus therapeutic market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The research presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. This market research report provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Astellas Pharma Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Other 1
  • Market segments
  • Comparison by Other1
  • Renal pruritus - Market size and forecast 2019-2024
  • Cholestatic pruritus - Market size and forecast 2019-2024
  • Hematologic pruritus - Market size and forecast 2019-2024
  • Endocrine pruritus - Market size and forecast 2019-2024
  • Oncological pruritus - Market size and forecast 2019-2024
  • Market opportunity by Other1
Customer landscape
  • Overview
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
Drivers, Challenges, and Trends
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Overview
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Allergan Plc
  • Astellas Pharma Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits

1. Key Finding 1
2. Key Finding 2
3. Key Finding 3
4. Key Finding 5
5. Key Finding 6
6. Key Finding 7
7. Key Finding 8
8. Parent market
9. Market characteristics
10. Offerings of vendors included in the market definition
11. Market segments
12. Global - Market size and forecast 2019 - 2024 ($ million)
13. Global market: Year-over-year growth 2019 - 2024 (%)
14. Five forces analysis 2019 & 2024
15. Bargaining power of buyers
16. Bargaining power of suppliers
17. Threat of new entrants
18. Threat of substitutes
19. Threat of rivalry
20. Market condition - Five forces 2019
21. Other1 - Market share 2019-2024 (%)
22. Comparison by Other1
23. Renal pruritus - Market size and forecast 2019-2024 ($ million)
24. Renal pruritus - Year-over-year growth 2019-2024 (%)
25. Cholestatic pruritus - Market size and forecast 2019-2024 ($ million)
26. Cholestatic pruritus - Year-over-year growth 2019-2024 (%)
27. Hematologic pruritus - Market size and forecast 2019-2024 ($ million)
28. Hematologic pruritus - Year-over-year growth 2019-2024 (%)
29. Endocrine pruritus - Market size and forecast 2019-2024 ($ million)
30. Endocrine pruritus - Year-over-year growth 2019-2024 (%)
31. Oncological pruritus - Market size and forecast 2019-2024 ($ million)
32. Oncological pruritus - Year-over-year growth 2019-2024 (%)
33. Market opportunity by Other1
34. Customer landscape
35. Market share by geography 2019-2024 (%)
36. Geographic comparison
37. North America - Market size and forecast 2019-2024 ($ million)
38. North America - Year-over-year growth 2019-2024 (%)
39. Europe - Market size and forecast 2019-2024 ($ million)
40. Europe - Year-over-year growth 2019-2024 (%)
41. APAC - Market size and forecast 2019-2024 ($ million)
42. APAC - Year-over-year growth 2019-2024 (%)
43. ROW - Market size and forecast 2019-2024 ($ million)
44. ROW - Year-over-year growth 2019-2024 (%)
45. Key leading countries
46. Market opportunity by geography ($ million)
47. Impact of drivers and challenges
48. Vendor landscape
49. Landscape disruption
50. Industry risks
51. Vendors covered
52. Market positioning of vendors
53. Abbott Laboratories - Overview
54. Abbott Laboratories - Business segments
55. Abbott Laboratories - Key offerings
56. Abbott Laboratories - Key customers
57. Abbott Laboratories - Segment focus
58. Allergan Plc - Overview
59. Allergan Plc - Business segments
60. Allergan Plc - Key offerings
61. Allergan Plc - Key customers
62. Allergan Plc - Segment focus
63. Astellas Pharma Inc. - Overview
64. Astellas Pharma Inc. - Business segments
65. Astellas Pharma Inc. - Key offerings
66. Astellas Pharma Inc. - Key customers
67. Astellas Pharma Inc. - Segment focus
68. Cipla Inc. - Overview
69. Cipla Inc. - Business segments
70. Cipla Inc. - Key offerings
71. Cipla Inc. - Key customers
72. Cipla Inc. - Segment focus
73. GlaxoSmithKline Plc - Overview
74. GlaxoSmithKline Plc - Business segments
75. GlaxoSmithKline Plc - Key offerings
76. GlaxoSmithKline Plc - Key customers
77. GlaxoSmithKline Plc - Segment focus
78. Merck & Co. Inc. - Overview
79. Merck & Co. Inc. - Business segments
80. Merck & Co. Inc. - Key offerings
81. Merck & Co. Inc. - Key customers
82. Merck & Co. Inc. - Segment focus
83. Novartis AG - Overview
84. Novartis AG - Business segments
85. Novartis AG - Key offerings
86. Novartis AG - Key customers
87. Novartis AG - Segment focus
88. Pfizer Inc. - Overview
89. Pfizer Inc. - Business segments
90. Pfizer Inc. - Key offerings
91. Pfizer Inc. - Key customers
92. Pfizer Inc. - Segment focus
93. Sanofi - Overview
94. Sanofi - Business segments
95. Sanofi - Key offerings
96. Sanofi - Key customers
97. Sanofi - Segment focus
98. Sun Pharmaceutical Industries Ltd. - Overview
99. Sun Pharmaceutical Industries Ltd. - Business segments
100. Sun Pharmaceutical Industries Ltd. - Key offerings
101. Sun Pharmaceutical Industries Ltd. - Key customers
102. Sun Pharmaceutical Industries Ltd. - Segment focus
103. Currency conversion rates for US$
104. Research Methodology
105. Research Methodology
106. Validation techniques employed for market sizing
107. Information sources
108. List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Allergan Plc
  • Astellas Pharma Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • MORE
The research team recognizes the following companies as the key players in the global pruritus therapeutic market: Abbott Laboratories, Allergan Plc, Astellas Pharma Inc., Cipla Inc., GlaxoSmithKline Plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, and Sun Pharmaceutical Industries Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is strong pipeline of expected launches."

According to the report, one of the major drivers for this market is the increasing prevalence of pruritus.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • Allergan Plc
  • Astellas Pharma Inc.
  • Cipla Inc.
  • GlaxoSmithKline Plc
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
Adroll
adroll